Logo image of CTM

CASTELLUM INC (CTM) Stock Fundamental Analysis

NYSEARCA:CTM - American Stock Exchange - US14838T2042 - Common Stock

1.07  -0.02 (-1.83%)

After market: 1.0198 -0.05 (-4.69%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CTM. CTM was compared to 82 industry peers in the IT Services industry. Both the profitability and financial health of CTM have multiple concerns. CTM does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CTM has reported negative net income.
In the past year CTM had a positive cash flow from operations.
CTM Yearly Net Income VS EBIT VS OCF VS FCFCTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -5M -10M -15M

1.2 Ratios

The Return On Assets of CTM (-33.09%) is worse than 83.54% of its industry peers.
Looking at the Return On Equity, with a value of -79.36%, CTM is doing worse than 78.48% of the companies in the same industry.
Industry RankSector Rank
ROA -33.09%
ROE -79.36%
ROIC N/A
ROA(3y)-43.17%
ROA(5y)N/A
ROE(3y)-91.11%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CTM Yearly ROA, ROE, ROICCTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 -20 -40 -60 -80 -100

1.3 Margins

CTM's Gross Margin of 41.13% is fine compared to the rest of the industry. CTM outperforms 62.03% of its industry peers.
In the last couple of years the Gross Margin of CTM has declined.
The Profit Margin and Operating Margin are not available for CTM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.76%
GM growth 5YN/A
CTM Yearly Profit, Operating, Gross MarginsCTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 20 -20 40

More info and screens

2

2. Health

2.1 Basic Checks

CTM does not have a ROIC to compare to the WACC, probably because it is not profitable.
CTM has more shares outstanding than it did 1 year ago.
CTM has a worse debt/assets ratio than last year.
CTM Yearly Shares OutstandingCTM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 10M 20M 30M 40M
CTM Yearly Total Debt VS Total AssetsCTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

CTM has an Altman-Z score of 0.47. This is a bad value and indicates that CTM is not financially healthy and even has some risk of bankruptcy.
CTM has a worse Altman-Z score (0.47) than 77.22% of its industry peers.
The Debt to FCF ratio of CTM is 4.35, which is a neutral value as it means it would take CTM, 4.35 years of fcf income to pay off all of its debts.
CTM has a Debt to FCF ratio of 4.35. This is comparable to the rest of the industry: CTM outperforms 53.16% of its industry peers.
CTM has a Debt/Equity ratio of 0.75. This is a neutral value indicating CTM is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.75, CTM is not doing good in the industry: 64.56% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 4.35
Altman-Z 0.47
ROIC/WACCN/A
WACC11.86%
CTM Yearly LT Debt VS Equity VS FCFCTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 5M 10M 15M

2.3 Liquidity

CTM has a Current Ratio of 1.11. This is a normal value and indicates that CTM is financially healthy and should not expect problems in meeting its short term obligations.
CTM's Current ratio of 1.11 is on the low side compared to the rest of the industry. CTM is outperformed by 72.15% of its industry peers.
A Quick Ratio of 1.11 indicates that CTM should not have too much problems paying its short term obligations.
CTM has a worse Quick ratio (1.11) than 69.62% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 1.11
CTM Yearly Current Assets VS Current LiabilitesCTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

3

3. Growth

3.1 Past

CTM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 62.53%, which is quite impressive.
CTM shows a small growth in Revenue. In the last year, the Revenue has grown by 3.12%.
CTM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 50.25% yearly.
EPS 1Y (TTM)62.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.95%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y50.25%
Revenue growth 5YN/A
Sales Q2Q%-1.13%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y61.9%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year20.37%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CTM Yearly Revenue VS EstimatesCTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CTM Yearly EPS VS EstimatesCTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 -0.05 -0.1 -0.15 -0.2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CTM. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CTM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CTM Price Earnings VS Forward Price EarningsCTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

CTM's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CTM is cheaper than 63.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 25.18
EV/EBITDA N/A
CTM Per share dataCTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CTM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CASTELLUM INC

NYSEARCA:CTM (1/22/2025, 8:16:28 PM)

After market: 1.0198 -0.05 (-4.69%)

1.07

-0.02 (-1.83%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)11-11 2024-11-11/bmo
Earnings (Next)N/A N/A
Inst Owners9.25%
Inst Owner Change0%
Ins Owners23.64%
Ins Owner Change2.81%
Market Cap60.04M
Analysts80
Price TargetN/A
Short Float %10.64%
Short Ratio0.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.32
P/FCF 25.18
P/OCF 25.17
P/B 4.99
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.18
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)0.04
FCFY3.97%
OCF(TTM)0.04
OCFY3.97%
SpS0.81
BVpS0.21
TBVpS-0.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -33.09%
ROE -79.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.13%
FCFM 5.23%
ROA(3y)-43.17%
ROA(5y)N/A
ROE(3y)-91.11%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.76%
GM growth 5YN/A
F-Score5
Asset Turnover1.58
Health
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 4.35
Debt/EBITDA N/A
Cap/Depr 0.04%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 1.11
Altman-Z 0.47
F-Score5
WACC11.86%
ROIC/WACCN/A
Cap/Depr(3y)1.89%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.1%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)62.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.95%
EPS Next Y61.9%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.12%
Revenue growth 3Y50.25%
Revenue growth 5YN/A
Sales Q2Q%-1.13%
Revenue Next Year20.37%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y42.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year154.59%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-353.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-328.69%
OCF growth 3YN/A
OCF growth 5YN/A